Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups

Figure 2

Western blot analysis. Western blot analysis was performed for alpha-2-HS-glycoprotein (a), leucine-rich alpha-2-glycoprotein (b), apolipoprotein A1 (c), and serum albumin (d) using pooled plasma samples of patients with four different MDS subgroups: refractory cytopenia with multilineage dysplasia (RCMD), refractory anemia or refractory anemia with ringed sideroblasts (RA-RARS), refractory anemia with excess blasts subtype 1 (RAEB-1), and refractory anemia with excess blasts subtype 2 (RAEB-2). For better clarity the western blot analysis results are shown as highlighted by brightness and contrast image adjustment.

(a)

(b)

(c)

(d)